Ownership and insider activity for DENTSPLY SIRONA Inc. (XRAY): recent transactions by executives and directors. Track how corporate insiders are trading the stock.
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
Price
| Price | $10.65 (closing price, November 4, 2026) |
| Market Cap | $2.1B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-30 | MAZELSKY JONATHAN JAY | A-Award | 3,323 | |
| 2026-08-10 | Fortson John C. | A-Award | 104,200 | $1.3M |
| 2026-08-10 | Fortson John C. | A-Award | 24,014 | |
| 2026-08-07 | Frohning Andrea L. | F-InKind | 802 | $10K |
| 2026-07-20 | Fortson John C. | |||
| 2026-06-30 | MAZELSKY JONATHAN JAY | A-Award | 2,841 | |
| 2026-06-12 | MAZELSKY JONATHAN JAY | P-Purchase | 10,000 | $101K |
| 2026-06-08 | Barton-Brobst Lindi Rene | |||
| 2026-06-08 | Barton-Brobst Lindi Rene | |||
| 2023-11-09 | Barton-Brobst Lindi Rene | 500 | $26K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383.9M | $320.6M | $309.6M | $405.0M | $438.0M | $339.0M | $365.0M | $334.0M | $272.0M | $326.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $636.0M | $746.2M | $701.9M | $828.0M | $706.0M | $803.0M | $685.0M | $756.0M | $606.0M | $688.0M |
| Inventory | $517.1M | $623.1M | $598.9M | $562.0M | $476.0M | $515.0M | $627.0M | $624.0M | $564.0M | $642.0M |
| Total Current Assets | $1.88B | $2.00B | $1.89B | $2.00B | $1.80B | $1.85B | $1.89B | $1.97B | $1.75B | $2.02B |
| Property, Plant & Equipment | $799.8M | $876.0M | $870.6M | $961.0M | $967.0M | $971.0M | $961.0M | $978.0M | $902.0M | $1.00B |
| Goodwill | $5.95B | $4.52B | $3.43B | $3.40B | $3.99B | $3.98B | $2.69B | $2.44B | $1.60B | $1.15B |
| Intangible Assets | $2.96B | $2.83B | $2.42B | $2.18B | $2.50B | $2.32B | $1.90B | $1.71B | $1.21B | $974.0M |
| Total Assets | $11.66B | $10.38B | $8.69B | $8.60B | $9.35B | $9.24B | $7.64B | $7.37B | $5.75B | $5.43B |
| Accounts Payable | $223.0M | $284.4M | $283.9M | $308.0M | $302.0M | $262.0M | $279.0M | $305.0M | $241.0M | $300.0M |
| Short-term Debt | $21.1M | $30.1M | $92.4M | $2.0M | $299.0M | $182.0M | $118.0M | $322.0M | $549.0M | $360.0M |
| Total Current Liabilities | $771.0M | $946.6M | $1.01B | $995.0M | $1.37B | $1.26B | $1.17B | $1.43B | $1.59B | $1.34B |
| Long-term Debt | $1.51B | $1.61B | $1.56B | $1.43B | $1.98B | $1.91B | $1.83B | $1.80B | $1.59B | $2.02B |
| Total Liabilities | $3.53B | $3.74B | $3.55B | $3.51B | $4.42B | $4.24B | $3.83B | $4.08B | $3.81B | $4.09B |
| Retained Earnings | $3.95B | $2.32B | $1.23B | $1.40B | $1.20B | $1.51B | $456.0M | $205.0M | -$835.0M | -$1.56B |
| Total Equity | $8.11B | $6.63B | $5.12B | $5.09B | $4.93B | $5.00B | $3.81B | $3.29B | $1.94B | $1.34B |
| Total Debt | $1.51B | $1.61B | $1.66B | $1.60B | $2.46B | $2.29B | $2.15B | $2.30B | $2.27B | $2.47B |
| Net Debt | $1.13B | $1.29B | $1.35B | $1.19B | $2.02B | $1.96B | $1.78B | $1.97B | $2.00B | $2.14B |
| Working Capital | $1.11B | $1.06B | $874.7M | $1.00B | $426.0M | $591.0M | $723.0M | $548.0M | $157.0M | $680.0M |
Financial Health
| Debt / Equity | 1.71 |
| Current Ratio | 1.63 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 0.91 |
Profitability
| Return on Equity | -39.81% |
| Return on Invested Capital | 10.03% |
| Return on Assets | -10.49% |
| Gross Margin | 49.52% |
| Operating Margin | 11.69% |
| Net Margin | -14.99% |
Related companies: ALGN · HSIC · NVST · ISRG · 0R29.L · BDX · 0R19.L · MDLN
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of XRAY: Overview · Financials · Valuation · Estimates · Technical
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks